HRP970155A2 - Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists - Google Patents

Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists

Info

Publication number
HRP970155A2
HRP970155A2 HR19610784.9A HRP970155A HRP970155A2 HR P970155 A2 HRP970155 A2 HR P970155A2 HR P970155 A HRP970155 A HR P970155A HR P970155 A2 HRP970155 A2 HR P970155A2
Authority
HR
Croatia
Prior art keywords
fluoralkoxy
fluoralkyl
substituted heterocyclic
bradykinin antagonists
heterocyclic bradykinin
Prior art date
Application number
HR19610784.9A
Other languages
English (en)
Inventor
Adalbert Wagner
Holger Heitsch
Gerhard Noelken
Klaus Wirt
Bernward Schoelkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HRP970155A2 publication Critical patent/HRP970155A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D257/12—Six-membered rings having four nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR19610784.9A 1996-03-19 1997-03-18 Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists HRP970155A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610784A DE19610784A1 (de) 1996-03-19 1996-03-19 Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
HRP970155A2 true HRP970155A2 (en) 1998-04-30

Family

ID=7788755

Family Applications (1)

Application Number Title Priority Date Filing Date
HR19610784.9A HRP970155A2 (en) 1996-03-19 1997-03-18 Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists

Country Status (24)

Country Link
US (1) US5859025A (fr)
EP (1) EP0796848B1 (fr)
JP (1) JP4199315B2 (fr)
KR (1) KR970065522A (fr)
AR (1) AR006261A1 (fr)
AT (1) ATE242215T1 (fr)
AU (1) AU1628397A (fr)
BR (1) BR9701332A (fr)
CA (1) CA2199925A1 (fr)
CZ (1) CZ81097A3 (fr)
DE (2) DE19610784A1 (fr)
DK (1) DK0796848T3 (fr)
ES (1) ES2196207T3 (fr)
HR (1) HRP970155A2 (fr)
HU (1) HUP9700595A1 (fr)
ID (1) ID16274A (fr)
IL (1) IL120477A0 (fr)
NO (1) NO971238L (fr)
PL (1) PL318924A1 (fr)
PT (1) PT796848E (fr)
SI (1) SI0796848T1 (fr)
SK (1) SK34897A3 (fr)
TR (1) TR199700206A2 (fr)
ZA (1) ZA972328B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712960A1 (de) 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
DK1106614T3 (da) * 1999-12-10 2004-04-13 Pfizer 5-leddede, heteroarylsubstituerede 1,4-dihydropyridinforbindelser som bradykininantagonister
JP2005525398A (ja) * 2002-04-10 2005-08-25 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ブラジキニン受容体モジュレーターとして有用な新規なヘテロアリールアルキルアミド誘導体
EP1914236A1 (fr) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Nouveaux dérivés d'hétéroarylalkylamide utiles en tant que modulateurs du récepteur de la bradykinine
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
US7256207B2 (en) 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
RU2007131400A (ru) 2005-03-01 2009-04-10 Вайет (Us) Соединения циннолина и их применение в качестве модуляторов х-рецепторов печени
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AR085073A1 (es) * 2012-01-11 2013-09-11 Richmond Sa Com Ind Y Financiera Lab Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden
SMT202200154T1 (it) 2017-11-24 2022-05-12 Pharvaris Netherlands B V Nuovi antagonisti del recettore della bradichinina b2
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38706A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
KR20240039185A (ko) 2021-08-05 2024-03-26 파르바리스 게엠베하 브래디키닌 b2-수용체 길항제의 경구 투여용 지질 기반 조성물
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (fr) 2022-03-25 2023-09-28 Pharvaris Gmbh Utilisations thérapeutiques d'antagonistes du récepteur b2 de la bradykinine
HRP20260166T1 (hr) 2022-03-25 2026-03-27 Pharvaris Gmbh Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996005202A1 (fr) * 1994-08-17 1996-02-22 Nippon Hypox Laboratories Inc. Derive de l'imidazoquinoleine
CN1168667A (zh) * 1994-10-27 1997-12-24 藤沢药品工业株式会社 用作缓激肽拮抗剂的吡啶并嘧啶酮,喹啉和稠合的n-杂环化合物

Also Published As

Publication number Publication date
KR970065522A (ko) 1997-10-13
AR006261A1 (es) 1999-08-11
TR199700206A2 (xx) 1997-10-21
NO971238D0 (no) 1997-03-18
ATE242215T1 (de) 2003-06-15
IL120477A0 (en) 1997-07-13
PL318924A1 (en) 1997-09-29
US5859025A (en) 1999-01-12
HUP9700595A1 (hu) 2000-08-28
CZ81097A3 (en) 1997-10-15
EP0796848B1 (fr) 2003-06-04
SK34897A3 (en) 1998-01-14
NO971238L (no) 1997-09-22
JP4199315B2 (ja) 2008-12-17
ZA972328B (en) 1997-09-19
ES2196207T3 (es) 2003-12-16
SI0796848T1 (en) 2003-12-31
PT796848E (pt) 2003-08-29
DE59710191D1 (de) 2003-07-10
MX9702028A (es) 1997-09-30
ID16274A (id) 1997-09-18
EP0796848A1 (fr) 1997-09-24
HU9700595D0 (en) 1997-05-28
DK0796848T3 (da) 2003-09-22
JPH107656A (ja) 1998-01-13
BR9701332A (pt) 1998-08-18
CA2199925A1 (fr) 1997-09-19
AU1628397A (en) 1997-09-25
DE19610784A1 (de) 1997-09-25

Similar Documents

Publication Publication Date Title
GB9602294D0 (en) Heterocyclic compounds
PL331795A1 (en) Heterocyclic metaloprotease inhibitors
GB9715892D0 (en) Heterocyclic compounds
GB9617305D0 (en) Heterocyclic compounds
SI0796848T1 (en) Fluoralkyl- and fluoralkoxy-substituted heterocyclic bradykinin antagonists
GB9706294D0 (en) Heterocyclic compound
EP0900204A4 (fr) Composes heterocycliques
GB9623283D0 (en) Heterocyclic derivatives
IL125904A0 (en) Tetrahydropyrimidine derivatives
EP0912183A4 (fr) Composes heterocycliques
EP0900217A4 (fr) Composes heterocycliques
EP0900219A4 (fr) Composes heterocycliques
EP1011665A4 (fr) Agents heterocycliques
GB9416895D0 (en) Angiotensin antagonists
GB9614763D0 (en) Heterocyclic compounds
GB9625492D0 (en) Heterocyclic compounds
GB9625458D0 (en) Heterocyclic compounds
ZA976145B (en) Heterocyclic compounds
GB9626856D0 (en) Heterocyclic compounds
GB9613026D0 (en) Heterocyclic compounds
GB9615982D0 (en) Heterocyclic compounds
GB9617306D0 (en) Heterocyclic compounds
ZA976147B (en) Heterocyclic compounds
GB9602157D0 (en) Heterocyclic compounds
GB9625495D0 (en) Heterocyclic compounds

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ODBC Application rejected